Chinese PE Firm HOPU, Bill Gates Invest In Long-Acting Drug Designer Lyndra
January 30, 2019 — 12:54 CST
This Data Is Locked!
This area is available only to Subscribers.
American drug delivery system developer Lyndra Therapeutics has raised US$55 million in a series B round of financing from Chinese private equity firm HOPU Investments... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals